Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with ...

In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine. This may suggest that psilocybin's ...

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, its ...

Two-thirds of participants in a small-scale clinical trial said they were in complete remission from depression five years later Interviews suggest the treatment helped patients see their depression ...

A landmark study challenges conventional wisdom about depression treatment, revealing that psilocybin therapy may match or exceed the effectiveness of traditional antidepressants. This research ...

(The Center Square) – Mental health care providers are rediscovering new uses for old medicines. Recent findings demonstrating the efficacy of psilocybin, the active ingredient in magic mushrooms, ...

Two-thirds of people who underwent psilocybin-assisted therapy remained free from depression five years later, according to recent research that offers the first long-term glimpse into the lasting ...

New Hampshire lawmakers advanced a bipartisan bill to legalize the regulated use of psilocybin for medical purposes, while ...

Control group outcomes in randomized trials of psilocybin indicated less improvement in depression scores compared with trials of other antidepressants, according to a meta-analysis, suggesting that ...